{"id":"https://openalex.org/W4414517367","doi":"https://doi.org/10.1016/j.rpth.2025.103196","title":"A minimum valency of 4 is required for robust activation of platelets in flow cytometry by multivalent nanobodies to Glycoprotein VI, C-type lectin-like receptor 2 and Platelet Endothelial Aggregation Receptor 1","display_name":"A minimum valency of 4 is required for robust activation of platelets in flow cytometry by multivalent nanobodies to Glycoprotein VI, C-type lectin-like receptor 2 and Platelet Endothelial Aggregation Receptor 1","publication_year":2025,"publication_date":"2025-09-25","ids":{"openalex":"https://openalex.org/W4414517367","doi":"https://doi.org/10.1016/j.rpth.2025.103196","pmid":"https://pubmed.ncbi.nlm.nih.gov/41158673","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12557594"},"language":"en","primary_location":{"id":"doi:10.1016/j.rpth.2025.103196","doi":"https://doi.org/10.1016/j.rpth.2025.103196","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rpth.2025.103196","pdf_url":null,"source":{"id":"https://openalex.org/S4210185368","display_name":"Research and Practice in Thrombosis and Haemostasis","issn_l":"2475-0379","issn":["2475-0379"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.rpth.2025.103196","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027548753","display_name":"Rachel E. Lamerton","orcid":"https://orcid.org/0000-0002-8931-7279","observed_orcids":["https://orcid.org/0000-0002-8931-7279"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachel E. Lamerton","raw_affiliation_strings":["Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK","Department of Immunology and Immunotherapy, College of Medicine and Health, University of Birmingham, Birmingham, UK"],"raw_orcid":"https://orcid.org/0000-0002-8931-7279","affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Department of Immunology and Immunotherapy, College of Medicine and Health, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061141800","display_name":"Eleyna M. Martin","orcid":"https://orcid.org/0000-0002-9799-4464","observed_orcids":["https://orcid.org/0000-0002-9799-4464"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Eleyna M. Martin","raw_affiliation_strings":["Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062866982","display_name":"Jacqueline F Perry","orcid":"https://orcid.org/0000-0002-9648-7313","observed_orcids":["https://orcid.org/0000-0002-9648-7313"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline Perry","raw_affiliation_strings":["Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033100102","display_name":"Adam F. Cunningham","orcid":"https://orcid.org/0000-0003-0248-964X","observed_orcids":["https://orcid.org/0000-0003-0248-964X"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adam F. Cunningham","raw_affiliation_strings":["Department of Immunology and Immunotherapy, College of Medicine and Health, University of Birmingham, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Immunotherapy, College of Medicine and Health, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057799772","display_name":"Steve P. Watson","orcid":"https://orcid.org/0000-0002-7846-7423","observed_orcids":["https://orcid.org/0000-0002-7846-7423"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Steve P. Watson","raw_affiliation_strings":["Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK"],"raw_orcid":"https://orcid.org/0000-0002-7846-7423","affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067192657","display_name":"Andrew L. Frelinger","orcid":"https://orcid.org/0000-0002-6871-7441","observed_orcids":["https://orcid.org/0000-0002-6871-7441"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew L. Frelinger","raw_affiliation_strings":["Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5057799772","https://openalex.org/A5067192657"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317","https://openalex.org/I79619799"],"apc_list":{"value":2250,"currency":"USD","value_usd":2250},"apc_paid":{"value":2250,"currency":"USD","value_usd":2250},"fwci":2.2168,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.8892642,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"9","issue":"7","first_page":"103196","last_page":"103196"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platelet-activation","display_name":"platelet activation","score":0.921999990940094},{"id":"https://openalex.org/keywords/nanobodies","display_name":"nanobodies","score":0.8140000104904175},{"id":"https://openalex.org/keywords/multivalency","display_name":"multivalency","score":0.6830000281333923},{"id":"https://openalex.org/keywords/glycoprotein-vi","display_name":"glycoprotein VI","score":0.9330000281333923},{"id":"https://openalex.org/keywords/clec-2","display_name":"CLEC-2","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pear1","display_name":"PEAR1","score":0.9240000247955322},{"id":"https://openalex.org/keywords/platelet-membrane-glycoproteins","display_name":"platelet membrane glycoproteins","score":0.7860000133514404},{"id":"https://openalex.org/keywords/p-selectin","display_name":"P-selectin","score":0.7239999771118164},{"id":"https://openalex.org/keywords/fibrinogen-binding","display_name":"fibrinogen binding","score":0.7599999904632568},{"id":"https://openalex.org/keywords/alpha-granules","display_name":"alpha-granules","score":0.7269999980926514},{"id":"https://openalex.org/keywords/lamp1","display_name":"LAMP1","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C2780573682","wikidata":"https://www.wikidata.org/wiki/Q14905651","display_name":"GPVI","level":4,"score":0.823199987411499},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8093000054359436},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.738099992275238},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.7286999821662903},{"id":"https://openalex.org/C3018697912","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Platelet activation","level":3,"score":0.629800021648407},{"id":"https://openalex.org/C26828662","wikidata":"https://www.wikidata.org/wiki/Q7202248","display_name":"Platelet membrane glycoprotein","level":3,"score":0.5357999801635742},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.4875999987125397},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.483599990606308},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4699000120162964},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.4537000060081482},{"id":"https://openalex.org/C2993802102","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet aggregation","level":3,"score":0.44369998574256897},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3919000029563904},{"id":"https://openalex.org/C2780009322","wikidata":"https://www.wikidata.org/wiki/Q7202246","display_name":"Platelet adhesiveness","level":4,"score":0.3862000107765198},{"id":"https://openalex.org/C139007053","wikidata":"https://www.wikidata.org/wiki/Q1412952","display_name":"Valency","level":2,"score":0.36419999599456787},{"id":"https://openalex.org/C2778442980","wikidata":"https://www.wikidata.org/wiki/Q17110527","display_name":"Glycoprotein Ib","level":4,"score":0.3400999903678894},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.29490000009536743},{"id":"https://openalex.org/C28005876","wikidata":"https://www.wikidata.org/wiki/Q189814","display_name":"Endocytosis","level":3,"score":0.2766999900341034},{"id":"https://openalex.org/C2777983669","wikidata":"https://www.wikidata.org/wiki/Q223143","display_name":"Granulocyte","level":2,"score":0.2718999981880188}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.rpth.2025.103196","doi":"https://doi.org/10.1016/j.rpth.2025.103196","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rpth.2025.103196","pdf_url":null,"source":{"id":"https://openalex.org/S4210185368","display_name":"Research and Practice in Thrombosis and Haemostasis","issn_l":"2475-0379","issn":["2475-0379"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11363781","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12557594","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:41158673","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41158673","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and practice in thrombosis and haemostasis","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/4408e300-1434-494e-bb96-3e5a456c4a5c","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/4408e300-1434-494e-bb96-3e5a456c4a5c","pdf_url":"https://pure-oai.bham.ac.uk/ws/files/279665096/LamertonRE2025Minimum_preproof.pdf","source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Lamerton, R, Martin, E M, Perry, J, Cunningham, A, Watson, S & Frelinger III, A L 2025, 'A minimal valency of four is required for robust activation of platelets by multivalent nanobodies to GPVI, CLEC-2 and PEAR1', Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2025.103196","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.rpth.2025.103196","doi":"https://doi.org/10.1016/j.rpth.2025.103196","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rpth.2025.103196","pdf_url":null,"source":{"id":"https://openalex.org/S4210185368","display_name":"Research and Practice in Thrombosis and Haemostasis","issn_l":"2475-0379","issn":["2475-0379"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1590412184","display_name":null,"funder_award_id":"NIHR 203326","funder_id":"https://openalex.org/F4320336705","funder_display_name":"Birmingham Biomedical Research Centre"},{"id":"https://openalex.org/G1596066185","display_name":"Investigating the mechanisms of thromboinflammation induced by infection","funder_award_id":"222389","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G1830233433","display_name":"Mechanisms of inflammatory disease.","funder_award_id":"108871","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G2063946307","display_name":null,"funder_award_id":"NIHR203326","funder_id":"https://openalex.org/F4320319992","funder_display_name":"British Heart Foundation"},{"id":"https://openalex.org/G2350218693","display_name":null,"funder_award_id":"NIHR203326","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G5929461812","display_name":"Accelerator Award","funder_award_id":"AA/18/2/34218","funder_id":"https://openalex.org/F4320319992","funder_display_name":"British Heart Foundation"},{"id":"https://openalex.org/G6570699103","display_name":"Investigating the mechanisms of thromboinflammation induced by infection","funder_award_id":"222389/Z/21/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G6784978058","display_name":"Mechanisms of inflammatory disease.","funder_award_id":"108871/B/15/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G6803412027","display_name":null,"funder_award_id":"CH 03/003","funder_id":"https://openalex.org/F4320319992","funder_display_name":"British Heart Foundation"},{"id":"https://openalex.org/G899502808","display_name":null,"funder_award_id":"AA/18/2/34218","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320319992","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04"},{"id":"https://openalex.org/F4320320339","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70"},{"id":"https://openalex.org/F4320336705","display_name":"Birmingham Biomedical Research Centre","ror":"https://ror.org/05ccjmp23"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1567813092","https://openalex.org/W1983611240","https://openalex.org/W1990451715","https://openalex.org/W1993695127","https://openalex.org/W1994254188","https://openalex.org/W2004476280","https://openalex.org/W2013886278","https://openalex.org/W2034125855","https://openalex.org/W2049884419","https://openalex.org/W2066764749","https://openalex.org/W2077584046","https://openalex.org/W2107255498","https://openalex.org/W2117066664","https://openalex.org/W2145094503","https://openalex.org/W2168094413","https://openalex.org/W2169596690","https://openalex.org/W2793062143","https://openalex.org/W2886135168","https://openalex.org/W2907399917","https://openalex.org/W2982710769","https://openalex.org/W2993894543","https://openalex.org/W3036353623","https://openalex.org/W3107329362","https://openalex.org/W3111917059","https://openalex.org/W3115415812","https://openalex.org/W3122889567","https://openalex.org/W3145325535","https://openalex.org/W3200709078","https://openalex.org/W3210362879","https://openalex.org/W4205642305","https://openalex.org/W4310089712","https://openalex.org/W4313892662","https://openalex.org/W4362698008","https://openalex.org/W4376112817","https://openalex.org/W4387296175","https://openalex.org/W4387453488","https://openalex.org/W4400881709","https://openalex.org/W4403097052"],"related_works":["https://openalex.org/W4387453488","https://openalex.org/W4403097052","https://openalex.org/W7214092417","https://openalex.org/W4362698008","https://openalex.org/W7154681831","https://openalex.org/W2512112977","https://openalex.org/W1661662746","https://openalex.org/W2043051756","https://openalex.org/W4375856095","https://openalex.org/W2804776321"],"abstract_inverted_index":{"Background:":[0],"We":[1],"have":[2],"reported":[3],"that":[4],"trivalent":[5,52,178],"and":[6,16,25,49,53,70,74,83,115,122,127,129,162],"tetravalent":[7,54,111,142],"nanobodies":[8,62,112,159,179,188],"against":[9],"glycoprotein":[10],"(GP)VI,":[11],"C-type":[12],"lectin-like":[13],"receptor":[14,20],"(CLEC)-2,":[15],"platelet":[17,40,86,100,105,123,194],"endothelial":[18],"aggregation":[19,24],"(PEAR)1":[21],"stimulate":[22,164],"powerful":[23,165],"adenosine":[26],"triphosphate":[27],"secretion":[28],"in":[29,39,67,89,149,155,173],"human":[30],"platelets.":[31],"Objectives:":[32],"This":[33],"study":[34],"aimed":[35],"to":[36,113,160],"evaluate":[37],"changes":[38],"surface":[41,87,124],"GPs":[42,88],"elicited":[43],"by":[44],"activation":[45,101,166],"of":[46,59,136,167,186,192],"GPVI,":[47],"CLEC-2,":[48],"PEAR1":[50,143],"using":[51,79,92],"nanobodies.":[55],"Methods:":[56],"The":[57,141,183],"effect":[58],"the":[60,103,137,187],"crosslinked":[61],"on":[63,84],"P-selectin":[64],"was":[65],"measured":[66],"whole":[68,90],"blood":[69,91],"washed":[71],"platelets":[72,168],"with":[73],"without":[75],"secondary":[76,99],"mediator":[77],"inhibitors":[78],"classical":[80],"flow":[81,94,109,174,195],"cytometry":[82,196],"16":[85],"multispectral":[93,108],"cytometry.":[95,175],"Results:":[96],",":[97],"indicating":[98],"despite":[102],"low":[104,170],"concentration.":[106],"By":[107],"cytometry,":[110],"GPVI":[114,161],"CLEC-2":[116,163],"stimulated":[117],"similar":[118],"maximal":[119],"fibrinogen":[120],"binding":[121],"\u03b1-granule":[125],"(TLT-1":[126],"CD154)":[128],"\u03b4-granule":[130],"(CD63)":[131],"markers,":[132],"but":[133,152],"lower":[134],"levels":[135],"lysosomal":[138],"marker":[139],"CD107a.":[140],"nanobody":[144],"showed":[145],"partial":[146,181],"agonist":[147],"activity":[148,154],"some":[150],"donors":[151],"full":[153],"others.":[156],"Conclusion:":[157],"Tetravalent":[158],"at":[169],"nanomolar":[171],"concentrations":[172],"In":[176],"contrast,":[177],"are":[180],"agonists.":[182],"defined":[184],"stoichiometry":[185],"will":[189],"aid":[190],"development":[191],"standardized":[193],"assays.":[197]},"counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-09-26T00:00:00"}